6β-Methylprednisolone Aceponate
● Under Development
| Catalogue No.: | VE0027820 |
|---|---|
| CAS No.: | N/A |
| Mol. Formula: | C27H36O7 |
| Mol. Weight: | 472.58 g/mol |
Additional information on
Parent drug
MethylprednisoloneIUPAC Name
(6R,8S,9S,10R,11S,13S,14S,17R)-17-(2-Acetoxyacetyl)-11-hydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionatePharmacopeial Synonyms
N/ASynonyms
N/ASmiles
CCC(O[C@]1(C(COC(C)=O)=O)CC[C@@]2([H])[C@]3([H])C[C@](C)([H])C4=CC(C=C[C@]4(C)[C@@]3([H])[C@](O)([H])C[C@]12C)=O)=OInChI
InChI=1S/C27H36O7/c1-6-23(32)34-27(22(31)14-33-16(3)28)10-8-19-18-11-15(2)20-12-17(29)7-9-25(20,4)24(18)21(30)13-26(19,27)5/h7,9,12,15,18-19,21,24,30H,6,8,10-11,13-14H2,1-5H3/t15-,18+,19+,21+,24-,25+,26+,27+/m1/s1Description
6β-Methylprednisolone Aceponate impurity presents as a related steroidal analog detected during synthetic and stability studies. Analytical profiling by HPLC with diode array detection and LC-MS confirms its retention time and exact mass consistent with methyl substitution at the 6beta position. The impurity can arise from incomplete esterification or methylation side reactions and may increase under elevated temperature or acidic conditions. Control strategies include optimized reaction stoichiometry, purified starting materials, and targeted chromatographic purification. Identification, quantitation, and specification setting per ICH Q3A and Q3B guidance are recommended to ensure safety, batch consistency, and regulatory compliance.Request a Quote
"*" indicates required fields









